MeSH term
Frequency | Condition_Probility | Comparative Study | 14 | 0.0 |
Female | 16 | 0.0 |
Humans | 57 | 0.0 |
Male | 15 | 0.0 |
Research Support, Non-U.S. Gov't | 43 | 0.0 |
Sex Factors | 2 | 0.0 |
Time Factors | 3 | 0.0 |
Animals | 23 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
Exons | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Mice | 7 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Transcription, Genetic | 4 | 0.0 |
Cross Reactions | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Ribosomal Proteins/*genetics | 5 | 5.0 |
Sensitivity and Specificity | 2 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Cattle | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Mammals | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
Molecular Sequence Data | 15 | 0.0 |
Molecular Weight | 7 | 0.0 |
Recombinant Proteins/chemistry | 2 | 0.0 |
Spectrum Analysis, Mass | 3 | 0.0 |
Base Sequence | 11 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Epitopes | 2 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Drosophila melanogaster | 2 | 1.0 |
Electrophoresis, Gel, Two-Dimensional | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 22 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
DNA Primers | 3 | 0.0 |
RNA, Messenger/genetics | 5 | 0.0 |
English Abstract | 4 | 0.0 |
Antibodies, Monoclonal/immunology | 3 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Line | 6 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Rats | 7 | 0.0 |
*Proteasome Endopeptidase Complex | 3 | 4.0 |
Reference Values | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
*Capsid Proteins | 2 | 1.0 |
Mutation | 2 | 0.0 |
Adult | 6 | 0.0 |
Feedback | 2 | 1.0 |
Antibodies, Monoclonal | 9 | 0.0 |
Antibody Specificity | 5 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Aged | 4 | 0.0 |
Middle Aged | 5 | 0.0 |
Platelet Activation/drug effects | 3 | 5.0 |
Immunoenzyme Techniques | 3 | 0.0 |
Lymphoproliferative Disorders/immunology/*virology | 2 | 66.0 |
Flow Cytometry | 9 | 0.0 |
Thrombin/pharmacology | 5 | 2.0 |
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 12.0 |
Epinephrine/pharmacology | 5 | 5.0 |
In Vitro | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Platelet Membrane Glycoproteins/analysis | 4 | 5.0 |
Prostaglandin Endoperoxides, Synthetic/pharmacology | 3 | 18.0 |
Thromboxane A2/analogs & derivatives/pharmacology | 2 | 25.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
*Gene Expression Regulation, Fungal | 2 | 4.0 |
Genetic Complementation Test | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Platelet Activation | 3 | 2.0 |
Platelet Membrane Glycoproteins/*analysis | 3 | 9.0 |
Plasmids | 2 | 0.0 |
Adenosine Diphosphate/pharmacology | 5 | 4.0 |
Cloning, Molecular | 2 | 0.0 |
Platelet Activation/*physiology | 2 | 3.0 |
Binding, Competitive | 2 | 0.0 |
P-Selectin | 9 | 16.0 |
Antibodies, Monoclonal/*immunology | 3 | 0.0 |
*Platelet Activation | 3 | 2.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Rats, Inbred Strains | 2 | 0.0 |
Thrombin/*pharmacology | 2 | 1.0 |
Restriction Mapping | 2 | 0.0 |
Blood Platelets/*immunology | 2 | 2.0 |
Antibodies, Monoclonal/diagnostic use | 3 | 0.0 |
Lung/*enzymology | 2 | 3.0 |
Microscopy, Electron | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
